Veradigm PE Ratio 2010-2022 | MDRX

Current and historical p/e ratio for Veradigm (MDRX) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of August 15, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Veradigm PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-08-15 4.60 0.00
2022-12-31 17.64 $-0.25 0.00
2022-09-30 15.23 $0.43 35.42
2022-06-30 14.83 $0.43 34.49
2022-03-31 22.52 $1.12 20.11
2021-12-31 18.45 $1.01 18.27
2021-09-30 13.37 $5.15 2.60
2021-06-30 18.51 $5.03 3.68
2021-03-31 15.02 $4.83 3.11
2020-12-31 14.44 $4.64 3.11
2020-09-30 8.14 $-0.30 0.00
2020-06-30 6.77 $-0.33 0.00
2020-03-31 7.04 $-1.18 0.00
2019-12-31 9.82 $-1.09 0.00
2019-09-30 10.98 $1.17 9.38
2019-06-30 11.63 $1.00 11.63
2019-03-31 9.54 $2.26 4.22
2018-12-31 9.64 $2.08 4.63
2018-09-30 14.25 $-0.03 0.00
2018-06-30 12.00 $0.01 1200.00
2018-03-31 12.35 $-1.20 0.00
2017-12-31 14.55 $-1.09 0.00
2017-09-30 14.23 $-1.16 0.00
2017-06-30 12.76 $-1.06 0.00
2017-03-31 12.68 $-0.26 0.00
2016-12-31 10.21 $-0.14 0.00
2016-09-30 13.17 $-0.01 0.00
2016-06-30 12.70 $0.02 635.00
2016-03-31 13.21 $0.06 220.17
2015-12-31 15.38 $-0.01 0.00
2015-09-30 12.40 $-0.11 0.00
2015-06-30 13.68 $-0.23 0.00
2015-03-31 11.96 $-0.31 0.00
2014-12-31 12.77 $-0.37 0.00
2014-09-30 13.42 $-0.48 0.00
2014-06-30 16.05 $-0.60 0.00
2014-03-31 18.03 $-0.64 0.00
2013-12-31 15.46 $-0.59 0.00
2013-09-30 14.87 $-0.61 0.00
2013-06-30 12.94 $-0.29 0.00
2013-03-31 13.59 $-0.12 0.00
2012-12-31 9.42 $-0.02 0.00
2012-09-30 12.42 $0.26 47.77
2012-06-30 10.93 $0.32 34.16
2012-03-31 16.60 $0.36 46.11
2011-12-31 18.94 $0.39 48.56
2011-09-30 18.02 $0.22 81.91
2011-06-30 19.42 $0.12 161.83
2011-03-31 20.99 $0.14 149.93
2010-12-31 19.27 $0.08 240.88
2010-09-30 18.47 $0.23 80.30
2010-06-30 16.10 $0.22 73.18
2010-05-31 18.81 $0.12 156.75
2010-03-31 19.58 $0.12 163.17
2010-02-28 17.89 $0.09 198.78
2009-12-31 20.23 $0.09 224.78
2009-11-30 19.20 $0.09 213.33
2009-09-30 20.27 $0.09 225.22
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.498B $0.588B
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.855B 58.34
Tempus AI (TEM) United States $12.773B 0.00
Doximity (DOCS) United States $12.199B 54.27
Hims & Hers Health (HIMS) United States $10.301B 85.22
IRhythm Technologies (IRTC) United States $5.159B 0.00
Hinge Health (HNGE) United States $4.608B 0.00
Privia Health (PRVA) United States $2.610B 193.36
Inspire Medical Systems (INSP) United States $2.596B 38.16
Phreesia (PHR) United States $1.708B 0.00
Enovis (ENOV) United States $1.689B 8.93
10x Genomics (TXG) United States $1.645B 0.00
Omnicell (OMCL) United States $1.456B 28.04
Schrodinger (SDGR) United States $1.422B 0.00
Azenta (AZTA) United States $1.393B 60.78
Clover Health Investments (CLOV) United States $1.358B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.092B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Zepp Health (ZEPP) Netherlands $0.491B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Talkspace (TALK) United States $0.429B 128.00
Carlsmed (CARL) $0.360B 0.00
Butterfly Network (BFLY) United States $0.360B 0.00
TruBridge (TBRG) United States $0.289B 50.74
Outset Medical (OM) United States $0.236B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.193B 0.00
CapsoVision (CV) United States $0.178B 0.00
MDxHealth SA (MDXH) Belgium $0.135B 0.00
American Well (AMWL) United States $0.115B 0.00
CareCloud (CCLD) United States $0.110B 5.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.064B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.035B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00